aibio.space desks
Every story on aibio.space is credited to the topic desk that covers that kind of event. Desks follow our editorial standards.
- aibio.space IPO Desk: Biotech, medtech and pharma IPOs: pricings, upsizes, closings, S-1 and F-1 filings, lock-ups and early trading. (79 stories)
- aibio.space Financings Desk: Equity raises: follow-on and public offerings, PIPEs and private placements, registered directs, ATM programs, shelf registrations, warrant deals and royalty or licence money of $5 million or more. (709 stories)
- aibio.space Debt Desk: Convertible notes, term loans, venture debt, credit facilities, notes offerings, refinancings, amendments, extensions, waivers and note exchanges. (314 stories)
- aibio.space Distress & Restructuring Desk: Going-concern warnings, bankruptcies, restructurings, wind-downs, workforce cuts, late filings, defaults and forbearance. (285 stories)
- aibio.space Listings & Compliance Desk: Exchange deficiency and delisting notices, regained compliance, reverse splits, uplistings, ticker changes, Form 25 and Form 15 filings and trading suspensions. (520 stories)
- aibio.space M&A & Licensing Desk: Mergers, acquisitions, tender offers, reverse mergers, SPAC deals, asset sales and Schedule 13D activism. (248 stories)
- aibio.space Legal & Regulatory Desk: Securities class actions, derivative suits, patent cases, SEC and DOJ matters, subpoenas and settlements. Law-firm claims are reported as allegations. (146 stories)
- aibio.space Earnings Desk: Quarterly and annual results: revenue, net loss, cash, runway and guidance, from 10-Q, 10-K, 20-F and 6-K filings and company releases. (93 stories)
- aibio.space Analysis Desk: Signed opinion on single public biotech companies: cash, runway, deal terms and what boards should explain, sourced to filings. (22 stories)
- aibio.space Newsroom: Company updates that fit no single desk: management changes, pipeline and partnership updates, investor events and other filings. (206 stories)
aibio